XEN1101
XPF-010-303
Phase 3 small_molecule active
Quick answer
XEN1101 for Primary Generalized Tonic-Clonic Seizures is a Phase 3 program (small_molecule) at Xenon Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xenon Pharmaceuticals
- Indication
- Primary Generalized Tonic-Clonic Seizures
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active